Test Directory
| Test Code | |||||
| SEQM2 | |||||
| Test Name | |||||
| Maternal Screening, Sequential, Specimen 2 | |||||
| CPT Codes | |||||
| 81511 | |||||
| Included Tests | |||||
|
|||||
| Expected Turnaround Time | |||||
| 2 - 5 days | |||||
| Clinical Utility | |||||
|
Screening test for open neural tube defects, Down syndrome, and trisomy 18. |
|||||
| Specimen and Container Info | |||||
|
Specimen Type: Serum Collection Container: Gold Top, Serum Separator Desired Specimen Volume: 5 mL |
|||||
| Collection Instructions | |||||
|
|||||
| Processing and Submission Instructions | |||||
|
|||||
| Patient Preparation | |||||
|
|||||
| Transport Instructions | |||||
|
Transport to the laboratory refrigerated. |
|||||
| Stability Requirements | |||||
|
|||||
| Causes for Rejection | |||||
|
|||||
| Methodology | |||||
| Chemiluminescent Immunoassay | |||||
| Reference Intervals | |||||
|
See patient report. |
|||||
| Limitations | |||||
|
Sequential screening requires two specimens: one collected in the first trimester and one in the second trimester. This test number is for the second trimester portion of the test. This is a screening test. A positive result means that diagnostic testing may be offered to the pregnant woman to determine if a neural tube defect or chromosome abnormality is present. |
|||||
| Alternate Names | |||||
|
|||||
| Reference Lab | |||||
| Labcorp Of America Holdings | |||||
| Testing Schedule | |||||
| Varies | |||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.